Krebs Emanuel, Urada Darren, Evans Elizabeth, Huang David, Hser Yih-Ing, Nosyk Bohdan
British Columbia Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada.
UCLA Integrated Substance Abuse Program, Los Angeles, CA, USA.
Addiction. 2017 May;112(5):838-851. doi: 10.1111/add.13729. Epub 2017 Feb 6.
Treatment for opioid use disorders (OUD) reduces the risk of mortality and infectious disease transmission; however, opportunities to quantify the potential economic benefits of associated decreases in drug-related crime are scarce. This paper aimed to estimate the costs of crime during and after periods of engagement in publicly funded treatment for OUD to compare total costs of crime during a hypothetical 6-month period following initiation of opioid agonist treatment (OAT) versus detoxification.
Retrospective, administrative data-based cohort study with comprehensive information on drug treatment and criminal justice systems interactions.
Publicly funded drug treatment facilities in California, USA (2006-10).
A total of 31 659 individuals admitted for the first time to treatment for OUD, and who were linked with criminal justice and mortality data, were followed during a median 2.3 years. Median age at first treatment admission was 32, 35.8% were women and 37.1% primarily used prescription opioids.
Daily costs of crime (US$2014) were calculated from a societal perspective and were composed of the costs of policing, court, corrections and criminal victimization. We estimated the average marginal effect of treatment engagement in OAT or detoxification adjusting for potential fixed and time-varying confounders, including drug use and criminal justice system involvement prior to treatment initiation.
Daily costs of crime during treatment compared with after treatment were $126 lower for OAT [95% confidence interval (CI) = $116, $136] and $144 lower for detoxification (95% CI = $135, $154). Summing the costs of crime during and after treatment over a hypothetical 6-month period using the observed median durations of OAT (161 days) and detoxification (19 days), we estimated that enrolling an individual in OAT as opposed to detoxification would save $17 550 ($16 840, $18 383).
In publicly funded drug treatment facilities in California, USA, engagement in treatment for opioid use disorders is associated with lower costs of crime in the 6 months following initiation of treatment, and the economic benefits were far greater for individuals receiving time-unlimited treatment.
阿片类物质使用障碍(OUD)的治疗可降低死亡率和传染病传播风险;然而,量化与药物相关犯罪减少相关的潜在经济效益的机会却很少。本文旨在估计参与公共资助的OUD治疗期间及之后的犯罪成本,以比较在阿片类激动剂治疗(OAT)开始后的假设6个月期间与戒毒期间的犯罪总成本。
基于行政数据的回顾性队列研究,包含有关药物治疗和刑事司法系统相互作用的全面信息。
美国加利福尼亚州的公共资助药物治疗设施(2006 - 2010年)。
共有31659名首次因OUD入院治疗且与刑事司法和死亡率数据相关联的个体,随访时间中位数为2.3年。首次治疗入院时的年龄中位数为32岁,35.8%为女性,37.1%主要使用处方阿片类药物。
从社会角度计算犯罪的每日成本(2014美元),包括警务、法庭、惩教和刑事受害成本。我们估计了参与OAT或戒毒治疗的平均边际效应,并对潜在的固定和随时间变化的混杂因素进行了调整,包括治疗开始前的药物使用和刑事司法系统参与情况。
与治疗后相比,治疗期间OAT的每日犯罪成本低126美元[95%置信区间(CI)=116美元,136美元],戒毒的每日犯罪成本低144美元(95%CI =135美元,154美元)。使用观察到的OAT(161天)和戒毒(19天)的中位数持续时间,计算假设6个月期间治疗期间及之后的犯罪成本总和,我们估计让一个人接受OAT而非戒毒可节省17550美元(16840美元,18383美元)。
在美国加利福尼亚州的公共资助药物治疗设施中,参与阿片类物质使用障碍治疗与治疗开始后的6个月内犯罪成本降低相关,对于接受无时间限制治疗的个体,经济效益更大。